nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilutamide—CYP2C19—coronary artery disease	0.235	1	CbGaD
Nilutamide—CYP2C8—Fenofibrate—coronary artery disease	0.0369	0.0704	CbGbCtD
Nilutamide—CYP2C8—Gemfibrozil—coronary artery disease	0.0295	0.0563	CbGbCtD
Nilutamide—CYP2C9—Fenofibrate—coronary artery disease	0.0257	0.0491	CbGbCtD
Nilutamide—CYP2C8—Clopidogrel—coronary artery disease	0.0256	0.0488	CbGbCtD
Nilutamide—CYP2C19—Gemfibrozil—coronary artery disease	0.0247	0.0472	CbGbCtD
Nilutamide—CYP2C8—Pitavastatin—coronary artery disease	0.0223	0.0427	CbGbCtD
Nilutamide—CYP2C19—Clopidogrel—coronary artery disease	0.0214	0.0409	CbGbCtD
Nilutamide—CYP2C9—Gemfibrozil—coronary artery disease	0.0206	0.0393	CbGbCtD
Nilutamide—CYP2C19—Telmisartan—coronary artery disease	0.0187	0.0358	CbGbCtD
Nilutamide—CYP2C9—Clopidogrel—coronary artery disease	0.0178	0.034	CbGbCtD
Nilutamide—CYP2C8—Acetylsalicylic acid—coronary artery disease	0.0161	0.0307	CbGbCtD
Nilutamide—CYP2C9—Pitavastatin—coronary artery disease	0.0156	0.0298	CbGbCtD
Nilutamide—CYP2C8—Simvastatin—coronary artery disease	0.0153	0.0292	CbGbCtD
Nilutamide—CYP2C9—Valsartan—coronary artery disease	0.0152	0.0289	CbGbCtD
Nilutamide—CYP2C19—Timolol—coronary artery disease	0.0151	0.0289	CbGbCtD
Nilutamide—CYP2C8—Pravastatin—coronary artery disease	0.015	0.0286	CbGbCtD
Nilutamide—CYP2C8—Lovastatin—coronary artery disease	0.015	0.0286	CbGbCtD
Nilutamide—CYP2C19—Rosuvastatin—coronary artery disease	0.0138	0.0264	CbGbCtD
Nilutamide—CYP2C8—Atorvastatin—coronary artery disease	0.0137	0.0261	CbGbCtD
Nilutamide—CYP2C19—Acetylsalicylic acid—coronary artery disease	0.0135	0.0257	CbGbCtD
Nilutamide—CYP2C19—Simvastatin—coronary artery disease	0.0128	0.0245	CbGbCtD
Nilutamide—CYP2C19—Lovastatin—coronary artery disease	0.0126	0.024	CbGbCtD
Nilutamide—CYP2C8—Losartan—coronary artery disease	0.0125	0.0238	CbGbCtD
Nilutamide—CYP2C9—Rosuvastatin—coronary artery disease	0.0115	0.0219	CbGbCtD
Nilutamide—CYP2C19—Atorvastatin—coronary artery disease	0.0115	0.0219	CbGbCtD
Nilutamide—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.0112	0.0214	CbGbCtD
Nilutamide—CYP2C9—Simvastatin—coronary artery disease	0.0107	0.0204	CbGbCtD
Nilutamide—CYP2C19—Losartan—coronary artery disease	0.0105	0.02	CbGbCtD
Nilutamide—CYP2C9—Pravastatin—coronary artery disease	0.0105	0.02	CbGbCtD
Nilutamide—CYP2C9—Lovastatin—coronary artery disease	0.0105	0.02	CbGbCtD
Nilutamide—CYP2C9—Atorvastatin—coronary artery disease	0.00952	0.0182	CbGbCtD
Nilutamide—CYP2C9—Losartan—coronary artery disease	0.00871	0.0166	CbGbCtD
Nilutamide—CYP2C9—cardial valve—coronary artery disease	0.00614	0.44	CbGeAlD
Nilutamide—POR—myocardium—coronary artery disease	0.00114	0.082	CbGeAlD
Nilutamide—POR—heart—coronary artery disease	0.000799	0.0573	CbGeAlD
Nilutamide—Flutamide—CYP2C19—coronary artery disease	0.000742	0.413	CrCbGaD
Nilutamide—AR—cardiac ventricle—coronary artery disease	0.000719	0.0515	CbGeAlD
Nilutamide—POR—cardiac atrium—coronary artery disease	0.000683	0.049	CbGeAlD
Nilutamide—Enzalutamide—CYP2C19—coronary artery disease	0.000679	0.378	CrCbGaD
Nilutamide—AR—myocardium—coronary artery disease	0.000676	0.0485	CbGeAlD
Nilutamide—POR—blood—coronary artery disease	0.000596	0.0427	CbGeAlD
Nilutamide—AR—heart—coronary artery disease	0.000472	0.0338	CbGeAlD
Nilutamide—AR—cardiovascular system—coronary artery disease	0.000446	0.0319	CbGeAlD
Nilutamide—AR—cardiac atrium—coronary artery disease	0.000404	0.0289	CbGeAlD
Nilutamide—Enzalutamide—ALB—coronary artery disease	0.000377	0.209	CrCbGaD
Nilutamide—AR—blood—coronary artery disease	0.000352	0.0252	CbGeAlD
Nilutamide—CYP2C9—heart—coronary artery disease	0.000339	0.0243	CbGeAlD
Nilutamide—CYP2C19—blood—coronary artery disease	0.000326	0.0234	CbGeAlD
Nilutamide—CYP2C9—cardiovascular system—coronary artery disease	0.00032	0.0229	CbGeAlD
Nilutamide—CYP2C8—blood—coronary artery disease	0.000285	0.0204	CbGeAlD
Nilutamide—CYP2C9—blood—coronary artery disease	0.000253	0.0181	CbGeAlD
Nilutamide—Rash—Fenofibrate—coronary artery disease	9.17e-05	0.000502	CcSEcCtD
Nilutamide—Dermatitis—Fenofibrate—coronary artery disease	9.16e-05	0.000501	CcSEcCtD
Nilutamide—Loss of consciousness—Timolol—coronary artery disease	9.16e-05	0.000501	CcSEcCtD
Nilutamide—Decreased appetite—Furosemide—coronary artery disease	9.14e-05	0.0005	CcSEcCtD
Nilutamide—Headache—Fenofibrate—coronary artery disease	9.11e-05	0.000498	CcSEcCtD
Nilutamide—Paraesthesia—Losartan—coronary artery disease	9.11e-05	0.000498	CcSEcCtD
Nilutamide—Gastrointestinal pain—Captopril—coronary artery disease	9.11e-05	0.000498	CcSEcCtD
Nilutamide—Cough—Timolol—coronary artery disease	9.09e-05	0.000497	CcSEcCtD
Nilutamide—Vomiting—Clopidogrel—coronary artery disease	9.09e-05	0.000497	CcSEcCtD
Nilutamide—Diarrhoea—Simvastatin—coronary artery disease	9.09e-05	0.000497	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Furosemide—coronary artery disease	9.08e-05	0.000497	CcSEcCtD
Nilutamide—Chest pain—Ramipril—coronary artery disease	9.07e-05	0.000496	CcSEcCtD
Nilutamide—Abdominal pain—Telmisartan—coronary artery disease	9.05e-05	0.000495	CcSEcCtD
Nilutamide—Body temperature increased—Telmisartan—coronary artery disease	9.05e-05	0.000495	CcSEcCtD
Nilutamide—Dyspnoea—Losartan—coronary artery disease	9.04e-05	0.000495	CcSEcCtD
Nilutamide—Vomiting—Lovastatin—coronary artery disease	9.03e-05	0.000494	CcSEcCtD
Nilutamide—Dizziness—Eplerenone—coronary artery disease	9.01e-05	0.000493	CcSEcCtD
Nilutamide—Rash—Clopidogrel—coronary artery disease	9.01e-05	0.000493	CcSEcCtD
Nilutamide—Dermatitis—Clopidogrel—coronary artery disease	9e-05	0.000493	CcSEcCtD
Nilutamide—Asthenia—Valsartan—coronary artery disease	9e-05	0.000492	CcSEcCtD
Nilutamide—Hypertension—Timolol—coronary artery disease	8.99e-05	0.000492	CcSEcCtD
Nilutamide—Constipation—Furosemide—coronary artery disease	8.99e-05	0.000492	CcSEcCtD
Nilutamide—Pain—Furosemide—coronary artery disease	8.99e-05	0.000492	CcSEcCtD
Nilutamide—Ill-defined disorder—Lisinopril—coronary artery disease	8.97e-05	0.000491	CcSEcCtD
Nilutamide—Discomfort—Ramipril—coronary artery disease	8.96e-05	0.00049	CcSEcCtD
Nilutamide—Asthenia—Olmesartan—coronary artery disease	8.95e-05	0.00049	CcSEcCtD
Nilutamide—Headache—Clopidogrel—coronary artery disease	8.95e-05	0.00049	CcSEcCtD
Nilutamide—Rash—Lovastatin—coronary artery disease	8.95e-05	0.00049	CcSEcCtD
Nilutamide—Dermatitis—Lovastatin—coronary artery disease	8.94e-05	0.000489	CcSEcCtD
Nilutamide—Anaemia—Lisinopril—coronary artery disease	8.93e-05	0.000489	CcSEcCtD
Nilutamide—Dyspepsia—Losartan—coronary artery disease	8.93e-05	0.000488	CcSEcCtD
Nilutamide—Feeling abnormal—Perindopril—coronary artery disease	8.91e-05	0.000488	CcSEcCtD
Nilutamide—Headache—Lovastatin—coronary artery disease	8.89e-05	0.000487	CcSEcCtD
Nilutamide—Pruritus—Valsartan—coronary artery disease	8.87e-05	0.000485	CcSEcCtD
Nilutamide—Dry mouth—Ramipril—coronary artery disease	8.87e-05	0.000485	CcSEcCtD
Nilutamide—Chest pain—Timolol—coronary artery disease	8.87e-05	0.000485	CcSEcCtD
Nilutamide—Vomiting—Ezetimibe—coronary artery disease	8.85e-05	0.000484	CcSEcCtD
Nilutamide—Gastrointestinal pain—Perindopril—coronary artery disease	8.84e-05	0.000484	CcSEcCtD
Nilutamide—Pruritus—Olmesartan—coronary artery disease	8.83e-05	0.000483	CcSEcCtD
Nilutamide—Decreased appetite—Losartan—coronary artery disease	8.82e-05	0.000482	CcSEcCtD
Nilutamide—Abdominal pain—Captopril—coronary artery disease	8.8e-05	0.000482	CcSEcCtD
Nilutamide—Body temperature increased—Captopril—coronary artery disease	8.8e-05	0.000482	CcSEcCtD
Nilutamide—Dizziness—Simvastatin—coronary artery disease	8.78e-05	0.00048	CcSEcCtD
Nilutamide—Rash—Ezetimibe—coronary artery disease	8.78e-05	0.00048	CcSEcCtD
Nilutamide—Dermatitis—Ezetimibe—coronary artery disease	8.77e-05	0.00048	CcSEcCtD
Nilutamide—Discomfort—Timolol—coronary artery disease	8.76e-05	0.000479	CcSEcCtD
Nilutamide—Asthenia—Niacin—coronary artery disease	8.75e-05	0.000479	CcSEcCtD
Nilutamide—Headache—Ezetimibe—coronary artery disease	8.72e-05	0.000477	CcSEcCtD
Nilutamide—Malaise—Lisinopril—coronary artery disease	8.72e-05	0.000477	CcSEcCtD
Nilutamide—Oedema—Ramipril—coronary artery disease	8.7e-05	0.000476	CcSEcCtD
Nilutamide—Dry mouth—Timolol—coronary artery disease	8.67e-05	0.000475	CcSEcCtD
Nilutamide—Pain—Losartan—coronary artery disease	8.67e-05	0.000475	CcSEcCtD
Nilutamide—Constipation—Losartan—coronary artery disease	8.67e-05	0.000475	CcSEcCtD
Nilutamide—Syncope—Lisinopril—coronary artery disease	8.67e-05	0.000474	CcSEcCtD
Nilutamide—Vomiting—Eplerenone—coronary artery disease	8.67e-05	0.000474	CcSEcCtD
Nilutamide—Feeling abnormal—Furosemide—coronary artery disease	8.66e-05	0.000474	CcSEcCtD
Nilutamide—Leukopenia—Lisinopril—coronary artery disease	8.65e-05	0.000473	CcSEcCtD
Nilutamide—Nausea—Fenofibrate—coronary artery disease	8.64e-05	0.000473	CcSEcCtD
Nilutamide—Pruritus—Niacin—coronary artery disease	8.63e-05	0.000472	CcSEcCtD
Nilutamide—Asthenia—Pravastatin—coronary artery disease	8.61e-05	0.000471	CcSEcCtD
Nilutamide—Gastrointestinal pain—Furosemide—coronary artery disease	8.6e-05	0.00047	CcSEcCtD
Nilutamide—Rash—Eplerenone—coronary artery disease	8.59e-05	0.00047	CcSEcCtD
Nilutamide—Dermatitis—Eplerenone—coronary artery disease	8.59e-05	0.00047	CcSEcCtD
Nilutamide—Diarrhoea—Valsartan—coronary artery disease	8.58e-05	0.000469	CcSEcCtD
Nilutamide—Shock—Ramipril—coronary artery disease	8.56e-05	0.000468	CcSEcCtD
Nilutamide—Abdominal pain—Perindopril—coronary artery disease	8.55e-05	0.000468	CcSEcCtD
Nilutamide—Body temperature increased—Perindopril—coronary artery disease	8.55e-05	0.000468	CcSEcCtD
Nilutamide—Diarrhoea—Olmesartan—coronary artery disease	8.54e-05	0.000467	CcSEcCtD
Nilutamide—Headache—Eplerenone—coronary artery disease	8.54e-05	0.000467	CcSEcCtD
Nilutamide—Oedema—Timolol—coronary artery disease	8.5e-05	0.000465	CcSEcCtD
Nilutamide—Pruritus—Pravastatin—coronary artery disease	8.49e-05	0.000465	CcSEcCtD
Nilutamide—Loss of consciousness—Lisinopril—coronary artery disease	8.49e-05	0.000465	CcSEcCtD
Nilutamide—Nausea—Clopidogrel—coronary artery disease	8.49e-05	0.000464	CcSEcCtD
Nilutamide—Vomiting—Simvastatin—coronary artery disease	8.44e-05	0.000462	CcSEcCtD
Nilutamide—Cough—Lisinopril—coronary artery disease	8.43e-05	0.000461	CcSEcCtD
Nilutamide—Nausea—Lovastatin—coronary artery disease	8.43e-05	0.000461	CcSEcCtD
Nilutamide—Hyperhidrosis—Ramipril—coronary artery disease	8.41e-05	0.00046	CcSEcCtD
Nilutamide—Rash—Simvastatin—coronary artery disease	8.37e-05	0.000458	CcSEcCtD
Nilutamide—Dermatitis—Simvastatin—coronary artery disease	8.37e-05	0.000458	CcSEcCtD
Nilutamide—Asthenia—Trandolapril—coronary artery disease	8.37e-05	0.000458	CcSEcCtD
Nilutamide—Shock—Timolol—coronary artery disease	8.37e-05	0.000458	CcSEcCtD
Nilutamide—Feeling abnormal—Losartan—coronary artery disease	8.36e-05	0.000457	CcSEcCtD
Nilutamide—Diarrhoea—Niacin—coronary artery disease	8.34e-05	0.000456	CcSEcCtD
Nilutamide—Asthenia—Enalapril—coronary artery disease	8.33e-05	0.000456	CcSEcCtD
Nilutamide—Headache—Simvastatin—coronary artery disease	8.32e-05	0.000455	CcSEcCtD
Nilutamide—Body temperature increased—Furosemide—coronary artery disease	8.31e-05	0.000455	CcSEcCtD
Nilutamide—Abdominal pain—Furosemide—coronary artery disease	8.31e-05	0.000455	CcSEcCtD
Nilutamide—Gastrointestinal pain—Losartan—coronary artery disease	8.29e-05	0.000454	CcSEcCtD
Nilutamide—Dizziness—Valsartan—coronary artery disease	8.29e-05	0.000454	CcSEcCtD
Nilutamide—Anorexia—Ramipril—coronary artery disease	8.29e-05	0.000454	CcSEcCtD
Nilutamide—Nausea—Ezetimibe—coronary artery disease	8.27e-05	0.000453	CcSEcCtD
Nilutamide—Dizziness—Olmesartan—coronary artery disease	8.25e-05	0.000452	CcSEcCtD
Nilutamide—Pruritus—Trandolapril—coronary artery disease	8.25e-05	0.000451	CcSEcCtD
Nilutamide—Chest pain—Lisinopril—coronary artery disease	8.23e-05	0.00045	CcSEcCtD
Nilutamide—Hyperhidrosis—Timolol—coronary artery disease	8.22e-05	0.00045	CcSEcCtD
Nilutamide—Asthenia—Telmisartan—coronary artery disease	8.22e-05	0.00045	CcSEcCtD
Nilutamide—Pruritus—Enalapril—coronary artery disease	8.22e-05	0.000449	CcSEcCtD
Nilutamide—Diarrhoea—Pravastatin—coronary artery disease	8.21e-05	0.000449	CcSEcCtD
Nilutamide—Discomfort—Lisinopril—coronary artery disease	8.13e-05	0.000445	CcSEcCtD
Nilutamide—Anorexia—Timolol—coronary artery disease	8.1e-05	0.000443	CcSEcCtD
Nilutamide—Pruritus—Telmisartan—coronary artery disease	8.1e-05	0.000443	CcSEcCtD
Nilutamide—Nausea—Eplerenone—coronary artery disease	8.1e-05	0.000443	CcSEcCtD
Nilutamide—Dizziness—Niacin—coronary artery disease	8.06e-05	0.000441	CcSEcCtD
Nilutamide—Dry mouth—Lisinopril—coronary artery disease	8.05e-05	0.00044	CcSEcCtD
Nilutamide—Body temperature increased—Losartan—coronary artery disease	8.02e-05	0.000439	CcSEcCtD
Nilutamide—Abdominal pain—Losartan—coronary artery disease	8.02e-05	0.000439	CcSEcCtD
Nilutamide—Asthenia—Captopril—coronary artery disease	7.99e-05	0.000437	CcSEcCtD
Nilutamide—Diarrhoea—Trandolapril—coronary artery disease	7.98e-05	0.000436	CcSEcCtD
Nilutamide—Vomiting—Valsartan—coronary artery disease	7.97e-05	0.000436	CcSEcCtD
Nilutamide—Diarrhoea—Enalapril—coronary artery disease	7.95e-05	0.000435	CcSEcCtD
Nilutamide—Dizziness—Pravastatin—coronary artery disease	7.94e-05	0.000434	CcSEcCtD
Nilutamide—Vomiting—Olmesartan—coronary artery disease	7.94e-05	0.000434	CcSEcCtD
Nilutamide—Rash—Valsartan—coronary artery disease	7.91e-05	0.000433	CcSEcCtD
Nilutamide—Dermatitis—Valsartan—coronary artery disease	7.9e-05	0.000432	CcSEcCtD
Nilutamide—Nausea—Simvastatin—coronary artery disease	7.89e-05	0.000432	CcSEcCtD
Nilutamide—Oedema—Lisinopril—coronary artery disease	7.89e-05	0.000432	CcSEcCtD
Nilutamide—Pruritus—Captopril—coronary artery disease	7.88e-05	0.000431	CcSEcCtD
Nilutamide—Rash—Olmesartan—coronary artery disease	7.87e-05	0.000431	CcSEcCtD
Nilutamide—Insomnia—Ramipril—coronary artery disease	7.87e-05	0.00043	CcSEcCtD
Nilutamide—Dermatitis—Olmesartan—coronary artery disease	7.86e-05	0.00043	CcSEcCtD
Nilutamide—Headache—Valsartan—coronary artery disease	7.86e-05	0.00043	CcSEcCtD
Nilutamide—Diarrhoea—Telmisartan—coronary artery disease	7.84e-05	0.000429	CcSEcCtD
Nilutamide—Headache—Olmesartan—coronary artery disease	7.82e-05	0.000428	CcSEcCtD
Nilutamide—Paraesthesia—Ramipril—coronary artery disease	7.81e-05	0.000427	CcSEcCtD
Nilutamide—Shock—Lisinopril—coronary artery disease	7.76e-05	0.000425	CcSEcCtD
Nilutamide—Asthenia—Perindopril—coronary artery disease	7.76e-05	0.000424	CcSEcCtD
Nilutamide—Dyspnoea—Ramipril—coronary artery disease	7.75e-05	0.000424	CcSEcCtD
Nilutamide—Vomiting—Niacin—coronary artery disease	7.75e-05	0.000424	CcSEcCtD
Nilutamide—Dizziness—Trandolapril—coronary artery disease	7.71e-05	0.000422	CcSEcCtD
Nilutamide—Insomnia—Timolol—coronary artery disease	7.69e-05	0.000421	CcSEcCtD
Nilutamide—Rash—Niacin—coronary artery disease	7.69e-05	0.000421	CcSEcCtD
Nilutamide—Dermatitis—Niacin—coronary artery disease	7.68e-05	0.00042	CcSEcCtD
Nilutamide—Dizziness—Enalapril—coronary artery disease	7.68e-05	0.00042	CcSEcCtD
Nilutamide—Dyspepsia—Ramipril—coronary artery disease	7.66e-05	0.000419	CcSEcCtD
Nilutamide—Pruritus—Perindopril—coronary artery disease	7.65e-05	0.000419	CcSEcCtD
Nilutamide—Headache—Niacin—coronary artery disease	7.64e-05	0.000418	CcSEcCtD
Nilutamide—Paraesthesia—Timolol—coronary artery disease	7.63e-05	0.000418	CcSEcCtD
Nilutamide—Vomiting—Pravastatin—coronary artery disease	7.63e-05	0.000418	CcSEcCtD
Nilutamide—Hyperhidrosis—Lisinopril—coronary artery disease	7.63e-05	0.000417	CcSEcCtD
Nilutamide—Diarrhoea—Captopril—coronary artery disease	7.62e-05	0.000417	CcSEcCtD
Nilutamide—Dyspnoea—Timolol—coronary artery disease	7.58e-05	0.000415	CcSEcCtD
Nilutamide—Dizziness—Telmisartan—coronary artery disease	7.57e-05	0.000414	CcSEcCtD
Nilutamide—Rash—Pravastatin—coronary artery disease	7.57e-05	0.000414	CcSEcCtD
Nilutamide—Dermatitis—Pravastatin—coronary artery disease	7.56e-05	0.000414	CcSEcCtD
Nilutamide—Decreased appetite—Ramipril—coronary artery disease	7.56e-05	0.000414	CcSEcCtD
Nilutamide—Asthenia—Furosemide—coronary artery disease	7.54e-05	0.000413	CcSEcCtD
Nilutamide—Headache—Pravastatin—coronary artery disease	7.52e-05	0.000411	CcSEcCtD
Nilutamide—Anorexia—Lisinopril—coronary artery disease	7.52e-05	0.000411	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Ramipril—coronary artery disease	7.51e-05	0.000411	CcSEcCtD
Nilutamide—Dyspepsia—Timolol—coronary artery disease	7.48e-05	0.000409	CcSEcCtD
Nilutamide—Nausea—Valsartan—coronary artery disease	7.45e-05	0.000408	CcSEcCtD
Nilutamide—Pruritus—Furosemide—coronary artery disease	7.44e-05	0.000407	CcSEcCtD
Nilutamide—Constipation—Ramipril—coronary artery disease	7.44e-05	0.000407	CcSEcCtD
Nilutamide—Nausea—Olmesartan—coronary artery disease	7.41e-05	0.000406	CcSEcCtD
Nilutamide—Vomiting—Trandolapril—coronary artery disease	7.41e-05	0.000406	CcSEcCtD
Nilutamide—Diarrhoea—Perindopril—coronary artery disease	7.4e-05	0.000405	CcSEcCtD
Nilutamide—Decreased appetite—Timolol—coronary artery disease	7.39e-05	0.000404	CcSEcCtD
Nilutamide—Vomiting—Enalapril—coronary artery disease	7.38e-05	0.000404	CcSEcCtD
Nilutamide—Dizziness—Captopril—coronary artery disease	7.37e-05	0.000403	CcSEcCtD
Nilutamide—Rash—Trandolapril—coronary artery disease	7.35e-05	0.000402	CcSEcCtD
Nilutamide—Dermatitis—Trandolapril—coronary artery disease	7.34e-05	0.000402	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Timolol—coronary artery disease	7.34e-05	0.000402	CcSEcCtD
Nilutamide—Rash—Enalapril—coronary artery disease	7.32e-05	0.000401	CcSEcCtD
Nilutamide—Dermatitis—Enalapril—coronary artery disease	7.32e-05	0.0004	CcSEcCtD
Nilutamide—Headache—Trandolapril—coronary artery disease	7.3e-05	0.0004	CcSEcCtD
Nilutamide—Vomiting—Telmisartan—coronary artery disease	7.28e-05	0.000398	CcSEcCtD
Nilutamide—Asthenia—Losartan—coronary artery disease	7.28e-05	0.000398	CcSEcCtD
Nilutamide—Headache—Enalapril—coronary artery disease	7.27e-05	0.000398	CcSEcCtD
Nilutamide—Pain—Timolol—coronary artery disease	7.27e-05	0.000398	CcSEcCtD
Nilutamide—Nausea—Niacin—coronary artery disease	7.24e-05	0.000396	CcSEcCtD
Nilutamide—Rash—Telmisartan—coronary artery disease	7.22e-05	0.000395	CcSEcCtD
Nilutamide—Dermatitis—Telmisartan—coronary artery disease	7.22e-05	0.000395	CcSEcCtD
Nilutamide—Diarrhoea—Furosemide—coronary artery disease	7.19e-05	0.000394	CcSEcCtD
Nilutamide—Pruritus—Losartan—coronary artery disease	7.18e-05	0.000393	CcSEcCtD
Nilutamide—Headache—Telmisartan—coronary artery disease	7.18e-05	0.000393	CcSEcCtD
Nilutamide—Feeling abnormal—Ramipril—coronary artery disease	7.17e-05	0.000392	CcSEcCtD
Nilutamide—Dizziness—Perindopril—coronary artery disease	7.15e-05	0.000391	CcSEcCtD
Nilutamide—Insomnia—Lisinopril—coronary artery disease	7.13e-05	0.00039	CcSEcCtD
Nilutamide—Nausea—Pravastatin—coronary artery disease	7.13e-05	0.00039	CcSEcCtD
Nilutamide—Gastrointestinal pain—Ramipril—coronary artery disease	7.11e-05	0.000389	CcSEcCtD
Nilutamide—Paraesthesia—Lisinopril—coronary artery disease	7.08e-05	0.000387	CcSEcCtD
Nilutamide—Vomiting—Captopril—coronary artery disease	7.08e-05	0.000387	CcSEcCtD
Nilutamide—Dyspnoea—Lisinopril—coronary artery disease	7.03e-05	0.000385	CcSEcCtD
Nilutamide—Rash—Captopril—coronary artery disease	7.02e-05	0.000384	CcSEcCtD
Nilutamide—Dermatitis—Captopril—coronary artery disease	7.02e-05	0.000384	CcSEcCtD
Nilutamide—Feeling abnormal—Timolol—coronary artery disease	7.01e-05	0.000383	CcSEcCtD
Nilutamide—Headache—Captopril—coronary artery disease	6.98e-05	0.000382	CcSEcCtD
Nilutamide—Gastrointestinal pain—Timolol—coronary artery disease	6.95e-05	0.00038	CcSEcCtD
Nilutamide—Dizziness—Furosemide—coronary artery disease	6.95e-05	0.00038	CcSEcCtD
Nilutamide—Dyspepsia—Lisinopril—coronary artery disease	6.94e-05	0.00038	CcSEcCtD
Nilutamide—Diarrhoea—Losartan—coronary artery disease	6.94e-05	0.00038	CcSEcCtD
Nilutamide—Nausea—Trandolapril—coronary artery disease	6.93e-05	0.000379	CcSEcCtD
Nilutamide—Nausea—Enalapril—coronary artery disease	6.9e-05	0.000377	CcSEcCtD
Nilutamide—Vomiting—Perindopril—coronary artery disease	6.88e-05	0.000376	CcSEcCtD
Nilutamide—Abdominal pain—Ramipril—coronary artery disease	6.88e-05	0.000376	CcSEcCtD
Nilutamide—Body temperature increased—Ramipril—coronary artery disease	6.88e-05	0.000376	CcSEcCtD
Nilutamide—Decreased appetite—Lisinopril—coronary artery disease	6.86e-05	0.000375	CcSEcCtD
Nilutamide—Rash—Perindopril—coronary artery disease	6.82e-05	0.000373	CcSEcCtD
Nilutamide—Dermatitis—Perindopril—coronary artery disease	6.81e-05	0.000373	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Lisinopril—coronary artery disease	6.81e-05	0.000373	CcSEcCtD
Nilutamide—Nausea—Telmisartan—coronary artery disease	6.8e-05	0.000372	CcSEcCtD
Nilutamide—Headache—Perindopril—coronary artery disease	6.77e-05	0.000371	CcSEcCtD
Nilutamide—Constipation—Lisinopril—coronary artery disease	6.75e-05	0.000369	CcSEcCtD
Nilutamide—Pain—Lisinopril—coronary artery disease	6.75e-05	0.000369	CcSEcCtD
Nilutamide—Abdominal pain—Timolol—coronary artery disease	6.72e-05	0.000368	CcSEcCtD
Nilutamide—Body temperature increased—Timolol—coronary artery disease	6.72e-05	0.000368	CcSEcCtD
Nilutamide—Dizziness—Losartan—coronary artery disease	6.71e-05	0.000367	CcSEcCtD
Nilutamide—Vomiting—Furosemide—coronary artery disease	6.68e-05	0.000366	CcSEcCtD
Nilutamide—Rash—Furosemide—coronary artery disease	6.63e-05	0.000363	CcSEcCtD
Nilutamide—Dermatitis—Furosemide—coronary artery disease	6.62e-05	0.000362	CcSEcCtD
Nilutamide—Nausea—Captopril—coronary artery disease	6.62e-05	0.000362	CcSEcCtD
Nilutamide—Headache—Furosemide—coronary artery disease	6.59e-05	0.00036	CcSEcCtD
Nilutamide—Feeling abnormal—Lisinopril—coronary artery disease	6.5e-05	0.000356	CcSEcCtD
Nilutamide—Gastrointestinal pain—Lisinopril—coronary artery disease	6.45e-05	0.000353	CcSEcCtD
Nilutamide—Vomiting—Losartan—coronary artery disease	6.45e-05	0.000353	CcSEcCtD
Nilutamide—Nausea—Perindopril—coronary artery disease	6.42e-05	0.000351	CcSEcCtD
Nilutamide—Rash—Losartan—coronary artery disease	6.4e-05	0.00035	CcSEcCtD
Nilutamide—Dermatitis—Losartan—coronary artery disease	6.39e-05	0.00035	CcSEcCtD
Nilutamide—Headache—Losartan—coronary artery disease	6.35e-05	0.000348	CcSEcCtD
Nilutamide—Nausea—Furosemide—coronary artery disease	6.24e-05	0.000342	CcSEcCtD
Nilutamide—Asthenia—Ramipril—coronary artery disease	6.24e-05	0.000341	CcSEcCtD
Nilutamide—Abdominal pain—Lisinopril—coronary artery disease	6.24e-05	0.000341	CcSEcCtD
Nilutamide—Body temperature increased—Lisinopril—coronary artery disease	6.24e-05	0.000341	CcSEcCtD
Nilutamide—Pruritus—Ramipril—coronary artery disease	6.15e-05	0.000337	CcSEcCtD
Nilutamide—Asthenia—Timolol—coronary artery disease	6.1e-05	0.000334	CcSEcCtD
Nilutamide—Nausea—Losartan—coronary artery disease	6.02e-05	0.00033	CcSEcCtD
Nilutamide—Pruritus—Timolol—coronary artery disease	6.02e-05	0.000329	CcSEcCtD
Nilutamide—Diarrhoea—Ramipril—coronary artery disease	5.95e-05	0.000326	CcSEcCtD
Nilutamide—Diarrhoea—Timolol—coronary artery disease	5.82e-05	0.000318	CcSEcCtD
Nilutamide—Dizziness—Ramipril—coronary artery disease	5.75e-05	0.000315	CcSEcCtD
Nilutamide—Asthenia—Lisinopril—coronary artery disease	5.66e-05	0.00031	CcSEcCtD
Nilutamide—Dizziness—Timolol—coronary artery disease	5.62e-05	0.000308	CcSEcCtD
Nilutamide—Pruritus—Lisinopril—coronary artery disease	5.58e-05	0.000305	CcSEcCtD
Nilutamide—Vomiting—Ramipril—coronary artery disease	5.53e-05	0.000303	CcSEcCtD
Nilutamide—Rash—Ramipril—coronary artery disease	5.48e-05	0.0003	CcSEcCtD
Nilutamide—Dermatitis—Ramipril—coronary artery disease	5.48e-05	0.0003	CcSEcCtD
Nilutamide—Headache—Ramipril—coronary artery disease	5.45e-05	0.000298	CcSEcCtD
Nilutamide—Vomiting—Timolol—coronary artery disease	5.41e-05	0.000296	CcSEcCtD
Nilutamide—Diarrhoea—Lisinopril—coronary artery disease	5.4e-05	0.000295	CcSEcCtD
Nilutamide—Rash—Timolol—coronary artery disease	5.36e-05	0.000293	CcSEcCtD
Nilutamide—Dermatitis—Timolol—coronary artery disease	5.36e-05	0.000293	CcSEcCtD
Nilutamide—Headache—Timolol—coronary artery disease	5.33e-05	0.000291	CcSEcCtD
Nilutamide—Dizziness—Lisinopril—coronary artery disease	5.22e-05	0.000285	CcSEcCtD
Nilutamide—Nausea—Ramipril—coronary artery disease	5.17e-05	0.000283	CcSEcCtD
Nilutamide—Nausea—Timolol—coronary artery disease	5.05e-05	0.000276	CcSEcCtD
Nilutamide—Vomiting—Lisinopril—coronary artery disease	5.02e-05	0.000274	CcSEcCtD
Nilutamide—Rash—Lisinopril—coronary artery disease	4.97e-05	0.000272	CcSEcCtD
Nilutamide—Dermatitis—Lisinopril—coronary artery disease	4.97e-05	0.000272	CcSEcCtD
Nilutamide—Headache—Lisinopril—coronary artery disease	4.94e-05	0.00027	CcSEcCtD
Nilutamide—Nausea—Lisinopril—coronary artery disease	4.69e-05	0.000256	CcSEcCtD
Nilutamide—CYP2C8—Metabolism—TXNRD1—coronary artery disease	1.1e-05	0.000259	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CYP11B2—coronary artery disease	1.1e-05	0.000259	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—SLC27A1—coronary artery disease	1.09e-05	0.000256	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—coronary artery disease	1.09e-05	0.000256	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—SULT1E1—coronary artery disease	1.08e-05	0.000256	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—SLC22A3—coronary artery disease	1.08e-05	0.000255	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—LCAT—coronary artery disease	1.07e-05	0.000251	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CPT1B—coronary artery disease	1.07e-05	0.000251	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—HADH—coronary artery disease	1.06e-05	0.000251	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ARNTL—coronary artery disease	1.06e-05	0.000251	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—coronary artery disease	1.05e-05	0.000248	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	1.05e-05	0.000247	CbGpPWpGaD
Nilutamide—AR—Gene Expression—MAPK14—coronary artery disease	1.05e-05	0.000247	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—APOA4—coronary artery disease	1.05e-05	0.000247	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—HK2—coronary artery disease	1.03e-05	0.000244	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—AKR1B1—coronary artery disease	1.03e-05	0.000244	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARGC1A—coronary artery disease	1.03e-05	0.000242	CbGpPWpGaD
Nilutamide—AR—Gene Expression—ESR1—coronary artery disease	1.03e-05	0.000242	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	1.02e-05	0.000241	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PDHA1—coronary artery disease	1.01e-05	0.000238	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GCLM—coronary artery disease	1.01e-05	0.000238	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GPX2—coronary artery disease	1.01e-05	0.000238	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PLA2G2A—coronary artery disease	1.01e-05	0.000238	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—APOA2—coronary artery disease	1.01e-05	0.000238	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GPX4—coronary artery disease	9.97e-06	0.000235	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—HK1—coronary artery disease	9.97e-06	0.000235	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ABCG5—coronary artery disease	9.97e-06	0.000235	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—SULT1A1—coronary artery disease	9.97e-06	0.000235	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	9.96e-06	0.000235	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—SLC27A1—coronary artery disease	9.91e-06	0.000234	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—HADHA—coronary artery disease	9.85e-06	0.000232	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—APOB—coronary artery disease	9.8e-06	0.000231	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—TXNRD1—coronary artery disease	9.79e-06	0.000231	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CYP11B2—coronary artery disease	9.79e-06	0.000231	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GSTA1—coronary artery disease	9.74e-06	0.00023	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—LCAT—coronary artery disease	9.72e-06	0.000229	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CPT1B—coronary artery disease	9.72e-06	0.000229	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—SLC22A3—coronary artery disease	9.64e-06	0.000227	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—LPA—coronary artery disease	9.63e-06	0.000227	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—APOA4—coronary artery disease	9.54e-06	0.000225	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ARNTL—coronary artery disease	9.5e-06	0.000224	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—HADH—coronary artery disease	9.5e-06	0.000224	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—coronary artery disease	9.37e-06	0.000221	CbGpPWpGaD
Nilutamide—AR—Gene Expression—PPARG—coronary artery disease	9.37e-06	0.000221	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	9.35e-06	0.000221	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PLCB3—coronary artery disease	9.32e-06	0.00022	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—APOA5—coronary artery disease	9.23e-06	0.000218	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PDHA1—coronary artery disease	9.21e-06	0.000217	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GCLM—coronary artery disease	9.21e-06	0.000217	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	9.13e-06	0.000215	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—P4HB—coronary artery disease	9.05e-06	0.000213	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PLA2G2A—coronary artery disease	9.01e-06	0.000212	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GPX2—coronary artery disease	9.01e-06	0.000212	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—APOA2—coronary artery disease	9.01e-06	0.000212	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	8.96e-06	0.000211	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—APOB—coronary artery disease	8.93e-06	0.000211	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—TXNRD1—coronary artery disease	8.92e-06	0.000211	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CYP11B2—coronary artery disease	8.92e-06	0.000211	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—SULT1A1—coronary artery disease	8.9e-06	0.00021	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ABCG5—coronary artery disease	8.9e-06	0.00021	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GPX4—coronary artery disease	8.9e-06	0.00021	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—HK1—coronary artery disease	8.9e-06	0.00021	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	8.89e-06	0.00021	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PLA2G1B—coronary artery disease	8.88e-06	0.00021	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—HADHA—coronary artery disease	8.79e-06	0.000207	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—SLC22A3—coronary artery disease	8.79e-06	0.000207	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	8.78e-06	0.000207	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GSTA1—coronary artery disease	8.69e-06	0.000205	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	8.68e-06	0.000205	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ARNTL—coronary artery disease	8.66e-06	0.000204	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—HADH—coronary artery disease	8.66e-06	0.000204	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—LPA—coronary artery disease	8.59e-06	0.000203	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	8.53e-06	0.000201	CbGpPWpGaD
Nilutamide—AR—Gene Expression—SERPINE1—coronary artery disease	8.44e-06	0.000199	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—VCAN—coronary artery disease	8.37e-06	0.000198	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PLCB3—coronary artery disease	8.32e-06	0.000196	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	8.32e-06	0.000196	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ALDOA—coronary artery disease	8.31e-06	0.000196	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—APOA5—coronary artery disease	8.24e-06	0.000194	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PLA2G2A—coronary artery disease	8.21e-06	0.000194	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—APOA2—coronary artery disease	8.21e-06	0.000194	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GPX2—coronary artery disease	8.21e-06	0.000194	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—SULT1A1—coronary artery disease	8.11e-06	0.000191	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—HK1—coronary artery disease	8.11e-06	0.000191	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ABCG5—coronary artery disease	8.11e-06	0.000191	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GPX4—coronary artery disease	8.11e-06	0.000191	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	8.1e-06	0.000191	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—P4HB—coronary artery disease	8.08e-06	0.000191	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—DCN—coronary artery disease	8.07e-06	0.00019	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—HADHA—coronary artery disease	8.02e-06	0.000189	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	8e-06	0.000189	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PLA2G1B—coronary artery disease	7.93e-06	0.000187	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GSTA1—coronary artery disease	7.92e-06	0.000187	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ALDH2—coronary artery disease	7.85e-06	0.000185	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	7.84e-06	0.000185	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—LPA—coronary artery disease	7.83e-06	0.000185	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	7.75e-06	0.000183	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	7.65e-06	0.00018	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PIK3C2A—coronary artery disease	7.65e-06	0.00018	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—LIPC—coronary artery disease	7.65e-06	0.00018	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—HBA1—coronary artery disease	7.65e-06	0.00018	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CYP2C19—coronary artery disease	7.65e-06	0.00018	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—APOC3—coronary artery disease	7.6e-06	0.000179	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PLCB3—coronary artery disease	7.59e-06	0.000179	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—LDLR—coronary artery disease	7.55e-06	0.000178	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	7.55e-06	0.000178	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—APOA5—coronary artery disease	7.51e-06	0.000177	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—VCAN—coronary artery disease	7.47e-06	0.000176	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GSTT1—coronary artery disease	7.46e-06	0.000176	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—SLC9A1—coronary artery disease	7.46e-06	0.000176	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ALDOA—coronary artery disease	7.42e-06	0.000175	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GCLC—coronary artery disease	7.38e-06	0.000174	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CETP—coronary artery disease	7.38e-06	0.000174	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—P4HB—coronary artery disease	7.37e-06	0.000174	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	7.3e-06	0.000172	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—SDC1—coronary artery disease	7.3e-06	0.000172	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PLA2G1B—coronary artery disease	7.23e-06	0.000171	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—DCN—coronary artery disease	7.2e-06	0.00017	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	7.15e-06	0.000169	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	7.07e-06	0.000167	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ALDH2—coronary artery disease	7e-06	0.000165	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PSMA6—coronary artery disease	6.89e-06	0.000163	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PSMB5—coronary artery disease	6.89e-06	0.000163	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	6.88e-06	0.000162	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	6.83e-06	0.000161	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—LIPC—coronary artery disease	6.83e-06	0.000161	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—HBA1—coronary artery disease	6.83e-06	0.000161	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PIK3C2A—coronary artery disease	6.83e-06	0.000161	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—VCAN—coronary artery disease	6.82e-06	0.000161	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—APOC3—coronary artery disease	6.78e-06	0.00016	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ALDOA—coronary artery disease	6.76e-06	0.00016	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—LDLR—coronary artery disease	6.74e-06	0.000159	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	6.73e-06	0.000159	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CTGF—coronary artery disease	6.73e-06	0.000159	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—HMGCR—coronary artery disease	6.67e-06	0.000157	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GOT2—coronary artery disease	6.67e-06	0.000157	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GSTT1—coronary artery disease	6.66e-06	0.000157	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—SLC9A1—coronary artery disease	6.66e-06	0.000157	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GCLC—coronary artery disease	6.59e-06	0.000155	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CETP—coronary artery disease	6.59e-06	0.000155	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—DCN—coronary artery disease	6.57e-06	0.000155	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—SDC1—coronary artery disease	6.51e-06	0.000154	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ALDH2—coronary artery disease	6.39e-06	0.000151	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	6.23e-06	0.000147	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—LIPC—coronary artery disease	6.22e-06	0.000147	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—HBA1—coronary artery disease	6.22e-06	0.000147	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CYP2C19—coronary artery disease	6.22e-06	0.000147	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PIK3C2A—coronary artery disease	6.22e-06	0.000147	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—APOC3—coronary artery disease	6.19e-06	0.000146	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PSMB5—coronary artery disease	6.15e-06	0.000145	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PSMA6—coronary artery disease	6.15e-06	0.000145	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—LDLR—coronary artery disease	6.15e-06	0.000145	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	6.14e-06	0.000145	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	6.14e-06	0.000145	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PLCB1—coronary artery disease	6.14e-06	0.000145	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GSTT1—coronary artery disease	6.07e-06	0.000143	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—SLC9A1—coronary artery disease	6.07e-06	0.000143	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	6.02e-06	0.000142	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CTGF—coronary artery disease	6.01e-06	0.000142	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CETP—coronary artery disease	6e-06	0.000142	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GCLC—coronary artery disease	6e-06	0.000142	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—HMGCR—coronary artery disease	5.96e-06	0.00014	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GOT2—coronary artery disease	5.96e-06	0.00014	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ABCA1—coronary artery disease	5.95e-06	0.00014	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—SDC1—coronary artery disease	5.94e-06	0.00014	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GGT1—coronary artery disease	5.76e-06	0.000136	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GOT1—coronary artery disease	5.76e-06	0.000136	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PSMA6—coronary artery disease	5.61e-06	0.000132	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PSMB5—coronary artery disease	5.61e-06	0.000132	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	5.6e-06	0.000132	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CTGF—coronary artery disease	5.48e-06	0.000129	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PLCB1—coronary artery disease	5.48e-06	0.000129	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—HMGCR—coronary artery disease	5.43e-06	0.000128	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GOT2—coronary artery disease	5.43e-06	0.000128	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	5.37e-06	0.000127	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ABCA1—coronary artery disease	5.31e-06	0.000125	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GSTP1—coronary artery disease	5.17e-06	0.000122	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GOT1—coronary artery disease	5.14e-06	0.000121	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GGT1—coronary artery disease	5.14e-06	0.000121	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PPARGC1A—coronary artery disease	5.13e-06	0.000121	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—HMOX1—coronary artery disease	5.1e-06	0.00012	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CAT—coronary artery disease	5.03e-06	0.000119	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PLCB1—coronary artery disease	4.99e-06	0.000118	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	4.9e-06	0.000116	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—APOB—coronary artery disease	4.89e-06	0.000115	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ABCA1—coronary artery disease	4.84e-06	0.000114	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GSTM1—coronary artery disease	4.75e-06	0.000112	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GGT1—coronary artery disease	4.69e-06	0.000111	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GOT1—coronary artery disease	4.69e-06	0.000111	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—LPL—coronary artery disease	4.67e-06	0.00011	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GSTP1—coronary artery disease	4.62e-06	0.000109	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PPARGC1A—coronary artery disease	4.58e-06	0.000108	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—HMOX1—coronary artery disease	4.55e-06	0.000107	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GPX1—coronary artery disease	4.55e-06	0.000107	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CAT—coronary artery disease	4.49e-06	0.000106	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CD36—coronary artery disease	4.43e-06	0.000105	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PPP2CA—coronary artery disease	4.38e-06	0.000103	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—APOB—coronary artery disease	4.36e-06	0.000103	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GSTM1—coronary artery disease	4.24e-06	0.0001	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GSTP1—coronary artery disease	4.21e-06	9.93e-05	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—MTHFR—coronary artery disease	4.2e-06	9.91e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	4.17e-06	9.84e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—LPL—coronary artery disease	4.17e-06	9.83e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—HMOX1—coronary artery disease	4.15e-06	9.8e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CAT—coronary artery disease	4.1e-06	9.67e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GPX1—coronary artery disease	4.06e-06	9.59e-05	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—AGT—coronary artery disease	3.99e-06	9.42e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—APOB—coronary artery disease	3.98e-06	9.38e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CD36—coronary artery disease	3.96e-06	9.34e-05	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—APOE—coronary artery disease	3.91e-06	9.23e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PPP2CA—coronary artery disease	3.91e-06	9.22e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GSTM1—coronary artery disease	3.87e-06	9.13e-05	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—APOA1—coronary artery disease	3.87e-06	9.12e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—LPL—coronary artery disease	3.8e-06	8.96e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—MTHFR—coronary artery disease	3.75e-06	8.85e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GPX1—coronary artery disease	3.71e-06	8.74e-05	CbGpPWpGaD
Nilutamide—AR—Gene Expression—AKT1—coronary artery disease	3.7e-06	8.74e-05	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	3.7e-06	8.73e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CD36—coronary artery disease	3.61e-06	8.51e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PPP2CA—coronary artery disease	3.56e-06	8.41e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—AGT—coronary artery disease	3.56e-06	8.41e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—APOE—coronary artery disease	3.49e-06	8.24e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—APOA1—coronary artery disease	3.45e-06	8.14e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—MTHFR—coronary artery disease	3.42e-06	8.07e-05	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PPARG—coronary artery disease	3.41e-06	8.04e-05	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—POMC—coronary artery disease	3.36e-06	7.93e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	3.3e-06	7.8e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—AGT—coronary artery disease	3.25e-06	7.66e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—APOE—coronary artery disease	3.18e-06	7.51e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—APOA1—coronary artery disease	3.15e-06	7.42e-05	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ALB—coronary artery disease	3.06e-06	7.23e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PPARG—coronary artery disease	3.04e-06	7.17e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	3.01e-06	7.11e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—POMC—coronary artery disease	3e-06	7.08e-05	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—NOS3—coronary artery disease	2.93e-06	6.91e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PPARG—coronary artery disease	2.77e-06	6.54e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—POMC—coronary artery disease	2.73e-06	6.45e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ALB—coronary artery disease	2.73e-06	6.45e-05	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PTGS2—coronary artery disease	2.68e-06	6.32e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—NOS3—coronary artery disease	2.62e-06	6.17e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ALB—coronary artery disease	2.49e-06	5.88e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PTGS2—coronary artery disease	2.39e-06	5.64e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—NOS3—coronary artery disease	2.39e-06	5.63e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PTGS2—coronary artery disease	2.18e-06	5.15e-05	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PIK3CA—coronary artery disease	1.65e-06	3.89e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PIK3CA—coronary artery disease	1.47e-06	3.47e-05	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—AKT1—coronary artery disease	1.35e-06	3.18e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PIK3CA—coronary artery disease	1.34e-06	3.17e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—AKT1—coronary artery disease	1.2e-06	2.84e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—AKT1—coronary artery disease	1.1e-06	2.59e-05	CbGpPWpGaD
